跳至主要内容
临床试验/TCTR20220731001
TCTR20220731001
招募中
4 期

Efficacy of Autologous Fibroblasts on Facial Rejuvenation: A Pilot Study

Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand0 个研究点目标入组 30 人2022年7月31日

概览

阶段
4 期
干预措施
未指定
疾病 / 适应症
Patient with wrinkle at cheek and periorbital with score of -2 to -1 by wrinkle patient assessment score
发起方
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
入组人数
30
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2022年7月31日
结束日期
2024年6月23日
最后更新
去年
研究类型
Interventional
性别
All

研究者

发起方
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

入排标准

入选标准

  • 1\. Aged 18 older
  • 2\. Patient with wrinkle at cheek and periorbital with score of \-2 to \-1 by wrinkle patient assessment score which have 5 score : Very satisfied(\+2\), Satisfied(\+1\), Mild satisfied(0\), not satisfied(\-1\), very not satified(\-2\)

排除标准

  • 1\. Patients who are pregnant, lactating, and postpartum.
  • 2\.Patient with autoimmune disease, transplantation, cancer, fibroblast or collagen genetic disorder for example Epidermolysis bullosa, Ataxia telangiectasis, skin cancer or others disease that affect the research.
  • 3\.Patient with history of treatment by autologous fibroblast .
  • 4\.Patient with history of treatment by inject any substances at cheek or lower face in 12 months before the research.
  • 5\.Patient with history of treatment by focus ultrasound or ablative laser or others that affect the cheek or lower face in 12 months before the research.
  • 6\.Patient with history of treatment by ultra phono, chemical peeling and cream or drug for treat wrinkle like tretinoin at cheek or lower face within 1 month.
  • 7\.Allergy to collagen , diary products, Gentamicin A, Amphotericin B and local anesthesia.
  • 8\.Patient with bleeding precaution, thrombocytopenia, take an anti\-platelet drug that cannot stop and taking steroid drug or immunosuppressive drug.
  • 9\.Patient with history of hypertrophic scar or Keloid .

结局指标

主要结局

未指定

相似试验